Top compounds associated with response to POLR2J3


Feature Type Standardized
Nominal ANOVA
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.04 0.2
mRNA L-685458 CTRPv2 pan-cancer AAC -0.044 0.2
mRNA SB-525334 CTRPv2 pan-cancer AAC 0.044 0.2
mRNA piperlongumine:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.042 0.3
mRNA carboplatin:UNC0638 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.045 0.3
mRNA thalidomide CTRPv2 pan-cancer AAC 0.064 0.3
mRNA BRD-K96970199 CTRPv2 pan-cancer AAC 0.082 0.3
mRNA Erlotinib UHNBreast pan-cancer AAC 0.32 0.3
mRNA TAE684 CTRPv2 pan-cancer AAC 0.041 0.3
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.042 0.3
Download CSV